Adjunctive Methylphenidate ER in Patients With Schizophrenia to Improve Functional and Cognitive Outcomes

Recruiting

Phase 2

Methylphenidate ERAdjunctive Methylphenidate ER in Patients With Schizophrenia to Improve Functional and Cognitive Outcomes

Sponsor:

The Royal Ottawa Mental Health Centre

Code:

NCT05414058

Conditions

Schizophrenia Schizoaffective

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

Apo-Methylphenidate ER

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-12-04. This information was provided to ClinicalTrials.gov by The Royal Ottawa Mental Health Centre on 2024-05-06.